Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
triglyceride
Pharma
In a big win for generics drugmakers, SCOTUS sides with Hikma
The U.S. Supreme Court has sided with Hikma, ruling that its generic version of Amarin’s Vascepa does not infringe patents held by the Irish company.
Kevin Dunleavy
Jun 4, 2026 3:11pm
Ionis doubles its sales projection for Tryngolza in sHTG to $2B
Jan 13, 2026 3:45pm
Ionis' Tryngolza win in sHTG sends shares soaring by 27%
Sep 2, 2025 11:30am
Ionis chalks up phase 3 trial win as it works to grow Tryngolza
May 19, 2025 12:10pm
Ionis, Arrowhead sponsor new triglyceride education group
Mar 28, 2025 10:10am
Tryngolza's FDA approval marks 'pivotal moment' for Ionis: CEO
Dec 20, 2024 8:32am
